CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
74.80
+0.28 (0.38%)
Feb 2, 2026, 10:36 AM EST - Market open
CVS Health Stock Forecast
Stock Price Forecast
The 19 analysts that cover CVS Health stock have a consensus rating of "Strong Buy" and an average price target of $93.05, which forecasts a 24.40% increase in the stock price over the next year. The lowest target is $70 and the highest is $102.
Price Target: $93.05 (+24.40%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 7 | 6 | 8 |
| Buy | 11 | 11 | 11 | 11 | 11 | 10 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 18 | 19 | 18 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Strong Buy Maintains $91 → $90 | Strong Buy | Maintains | $91 → $90 | +20.32% | Jan 28, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $100 → $95 | Strong Buy | Maintains | $100 → $95 | +27.01% | Jan 27, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $93 → $101 | Buy | Maintains | $93 → $101 | +35.03% | Dec 17, 2025 |
| Bernstein | Bernstein | Hold Maintains $86 → $87 | Hold | Maintains | $86 → $87 | +16.31% | Dec 12, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $95 → $98 | Strong Buy | Maintains | $95 → $98 | +31.02% | Dec 10, 2025 |
Financial Forecast
Revenue This Year
404.05B
from 370.66B
Increased by 9.01%
Revenue Next Year
414.53B
from 404.05B
Increased by 2.59%
EPS This Year
6.72
from 3.66
Increased by 83.58%
EPS Next Year
7.24
from 6.72
Increased by 7.75%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 424.1B | 453.9B | ||||
| Avg | 404.0B | 414.5B | ||||
| Low | 390.1B | 391.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 14.4% | 12.3% | ||||
| Avg | 9.0% | 2.6% | ||||
| Low | 5.3% | -3.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 7.04 | 7.88 | ||||
| Avg | 6.72 | 7.24 | ||||
| Low | 6.47 | 6.77 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 92.2% | 17.2% | ||||
| Avg | 83.6% | 7.8% | ||||
| Low | 76.7% | 0.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.